Literature DB >> 9463398

Conformational correction mechanisms aiding antigen recognition by a humanized antibody.

M A Holmes1, T N Buss, J Foote.   

Abstract

The crystal structure of the complex between hen egg lysozyme and the Fv fragment of a humanized antilysozyme antibody was determined to 2.7-A resolution. The structure of the antigen combining site in the complex is nearly identical to that of the complexed form of the parent mouse antibody, D1.3. In contrast, the combining sites of the unliganded mouse and humanized antilysozymes show moderate conformational differences. This disparity suggests that a conformational readjustment process linked to antigen binding reverses adverse conformations in the complementarity determining regions that had been introduced by engineering these segments next to human framework regions in the humanized antibody.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9463398      PMCID: PMC2212146          DOI: 10.1084/jem.187.4.479

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution.

Authors:  O Epp; E E Lattman; M Schiffer; R Huber; W Palm
Journal:  Biochemistry       Date:  1975-11-04       Impact factor: 3.162

2.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

Authors:  J M Rini; U Schulze-Gahmen; I A Wilson
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

3.  Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding.

Authors:  T N Bhat; G A Bentley; T O Fischmann; G Boulot; R J Poljak
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

4.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

5.  Replacing the complementarity-determining regions in a human antibody with those from a mouse.

Authors:  P T Jones; P H Dear; J Foote; M S Neuberger; G Winter
Journal:  Nature       Date:  1986 May 29-Jun 4       Impact factor: 49.962

6.  Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2,8-A resolution.

Authors:  R J Poljak; L M Amzel; H P Avey; B L Chen; R P Phizackerley; F Saul
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains.

Authors:  E A Kabat; T T Wu
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

8.  Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.

Authors:  F Matsuda; E K Shin; H Nagaoka; R Matsumura; M Haino; Y Fukita; S Taka-ishi; T Imai; J H Riley; R Anand
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

9.  Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Authors:  S L Morrison; M J Johnson; L A Herzenberg; V T Oi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  Kinetic evidence for hapten-induced conformational transition in immunoglobin MOPC 460.

Authors:  D Lancet; I Pecht
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  6 in total

1.  Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.

Authors:  Takeshi Nakanishi; Kouhei Tsumoto; Akiko Yokota; Hidemasa Kondo; Izumi Kumagai
Journal:  Protein Sci       Date:  2008-02       Impact factor: 6.725

2.  Probing orientation of immobilized humanized anti-lysozyme variable fragment by time-of-flight secondary-ion mass spectrometry.

Authors:  J E Baio; Fang Cheng; Daniel M Ratner; Patrick S Stayton; David G Castner
Journal:  J Biomed Mater Res A       Date:  2011-02-09       Impact factor: 4.396

3.  Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes.

Authors:  Sherry L La Porte; Charles Eigenbrot; Mark Ultsch; Wei-Hsien Ho; Davide Foletti; Alison Forgie; Kevin C Lindquist; David L Shelton; Jaume Pons
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

Review 4.  Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies.

Authors:  G Malviya; F Conti; M Chianelli; F Scopinaro; R A Dierckx; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-24       Impact factor: 9.236

5.  Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing.

Authors:  Charles M Forsyth; Veronica Juan; Yoshiko Akamatsu; Robert B DuBridge; Minhtam Doan; Alexander V Ivanov; Zhiyuan Ma; Dixie Polakoff; Jennifer Razo; Keith Wilson; David B Powers
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

6.  3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 target.

Authors:  Benoît Grellier; Fabrice Le Pogam; Marc Vitorino; Jean-Philippe Starck; Michel Geist; Vanessa Duong; Hélène Haegel; Thierry Menguy; Jean-Yves Bonnefoy; Jean-Baptiste Marchand; Philippe Ancian
Journal:  MAbs       Date:  2014-01-06       Impact factor: 5.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.